Cigna Group (NYSE:CI - Get Free Report)'s stock price fell 5.8% during trading on Thursday. The company traded as low as $269.26 and last traded at $268.8550. Approximately 929,986 shares traded hands during trading, a decline of 44% from the average daily volume of 1,670,066 shares. The stock had previously closed at $285.37.
Recent Cigna Group Headlines
Here are a few of the latest headlines about CI:
- Positive Sentiment: RBC raised its price target to $346 from $337 and reiterated an “Outperform” rating, signaling continued analyst confidence. RBC price-target update
- Neutral Sentiment: Cigna announced a three-year community-impact strategy supporting youth mental health, veterans, and people with complex health conditions. The initiative highlights corporate commitments but is unlikely to materially affect near-term earnings. Community strategy announcement
- Negative Sentiment: Investors are reacting to CMS’s proposed CRUSH rule, which would expand oversight and audits across government healthcare programs, including Medicare Advantage and Part D. The proposal raises potential compliance and repayment concerns for the managed-care sector. Cigna sold its Medicare Advantage, Part D, and related businesses in 2025, so its direct exposure is more limited; the selling may largely reflect sector-wide pressure. CMS rule and managed-care stocks
Analyst Ratings Changes
A number of equities analysts recently weighed in on the stock. Raymond James Financial lowered shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and decreased their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Piper Sandler cut their target price on Cigna Group from $370.00 to $360.00 and set an "overweight" rating on the stock in a research note on Thursday, November 12th. Wells Fargo & Company lifted their target price on Cigna Group from $307.00 to $325.00 and gave the stock an "equal weight" rating in a report on Friday, November 13th. Sanford C. Bernstein boosted their price target on Cigna Group from $387.00 to $390.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 11th. Finally, Wall Street Zen raised Cigna Group from a "hold" rating to a "buy" rating in a report on Sunday, November 8th. Fourteen equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $337.35.
Read Our Latest Analysis on CI
Cigna Group Price Performance
The business's 50 day moving average price is $288.37 and its 200 day moving average price is $283.00. The stock has a market capitalization of $72.23 billion, a P/E ratio of 12.10, a price-to-earnings-growth ratio of 1.10 and a beta of 0.25. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74.
Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, beating analysts' consensus estimates of $7.52 by $0.46. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The company had revenue of $73.79 billion for the quarter, compared to the consensus estimate of $72.64 billion. During the same quarter in the prior year, the firm earned $7.83 earnings per share. The firm's revenue for the quarter was up 5.6% compared to the same quarter last year. Sell-side analysts forecast that Cigna Group will post 30.71 EPS for the current year.
Cigna Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, December 3rd. Cigna Group's dividend payout ratio is presently 27.54%.
Insider Buying and Selling at Cigna Group
In other news, insider Everett Neville sold 617 shares of the firm's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of CI. BlackRock Inc. increased its position in shares of Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider's stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the last quarter. Dodge & Cox boosted its holdings in shares of Cigna Group by 0.7% in the third quarter. Dodge & Cox now owns 12,255,467 shares of the health services provider's stock worth $3,331,404,000 after buying an additional 81,592 shares during the last quarter. GQG Partners LLC purchased a new position in shares of Cigna Group in the second quarter worth approximately $1,628,918,000. Bank of America Corp DE boosted its holdings in shares of Cigna Group by 8.8% in the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider's stock worth $848,821,000 after buying an additional 256,677 shares during the last quarter. Finally, Boston Partners grew its position in Cigna Group by 17.9% during the third quarter. Boston Partners now owns 2,374,437 shares of the health services provider's stock valued at $645,467,000 after buying an additional 359,777 shares during the period. Institutional investors own 86.99% of the company's stock.
Cigna Group Company Profile
(
Get Free Report)
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.